naproxen has been researched along with Carcinoma 256, Walker in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Curi, R; FabrÃcio, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E | 1 |
Aikawa, J; Bonato, SJ; Curi, R; de Oliveira, HH; Facin, M; Fernandes, LC; Fernandez, R; Ferraz, AC; Folador, A; Grohs, H; Naliwaiko, K; Nishiyama, A; Pinto, JA; Pizato, N; Yamazaki, RK | 1 |
2 other study(ies) available for naproxen and Carcinoma 256, Walker
Article | Year |
---|---|
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eating; Energy Intake; Glycogen; Insulin; Kidney; Liver; Muscle, Skeletal; Naproxen; Rats; Rats, Wistar | 2003 |
Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia in Walker 256 tumor-bearing rats.
Topics: Animals; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Female; Fish Oils; Insulin; Naproxen; Rats; Rats, Wistar | 2004 |